Step-by-Step Clinical Nutrition Assessment for Transition from Enteral to Parenteral Nutrition
Begin nutritional screening immediately using a validated tool such as NRS-2002, MUST, or Subjective Global Assessment (SGA) to identify patients at nutritional risk who may require transition from EN to PN. 1, 2, 3
Initial Assessment Components
1. Determine Adequacy of Current Enteral Nutrition
- Monitor EN tolerance over 3-7 days: Document if patient is achieving <60% of caloric requirements via the enteral route despite optimization efforts 4, 5
- Assess gastrointestinal function: Look for absolute contraindications including intestinal obstruction, abdominal compartment syndrome, prolonged paralytic ileus, high-output fistula without distal feeding access, intestinal ischemia, or severe shock 6, 4
- Evaluate feeding intolerance symptoms: Document persistent abdominal pain, distension, increasing intra-abdominal pressure, or uncontrolled vomiting despite prokinetics and postpyloric feeding attempts 6
- Calculate actual intake: If EN provides <60% of estimated requirements for more than 7-10 days, transition to PN or supplemental PN is indicated 7, 4
2. Assess Nutritional Status and Risk Stratification
Identify severe nutritional risk using these specific criteria 4:
- Weight loss >10-15% within 6 months
- BMI <18.5 kg/m²
- Subjective Global Assessment Grade C
- Serum albumin <30 g/L (without hepatic or renal dysfunction)
Additional anthropometric measurements 2, 8:
- Current body weight versus usual/ideal body weight
- Mid-arm circumference and triceps skinfold thickness
- Handgrip strength for functional assessment 1
3. Calculate Energy and Protein Requirements
- Standard patients: 25-35 kcal/kg actual body weight/day
- Polymorbid older patients (≥65 years): approximately 27 kcal/kg/day
- Severely underweight patients: 30 kcal/kg actual body weight (advance cautiously due to refeeding risk) 3
- ICU patients: Use indirect calorimetry when available; otherwise 1.3 × REE 2, 10
- Standard unstressed patients: 0.8-1.0 g/kg/day
- Metabolically stressed or malnourished patients: 1.2-1.5 g/kg/day
- Polymorbid medical inpatients: 1.1-1.5 g/kg/day
- Patients with impaired kidney function (eGFR <30 ml/min) not on dialysis: 0.8 g/kg/day 3
4. Evaluate Timing for PN Initiation
Immediate PN initiation is indicated when 2, 4, 11:
- Moderately or severely malnourished patients cannot be fed sufficiently orally or enterally (Grade A recommendation)
- Fasting period anticipated to last >72 hours
- Patient at severe nutritional risk and EN is contraindicated or not feasible
Supplemental PN (combined EN/PN) should be considered when 7, 5:
- EN alone cannot achieve >60% of caloric goals after 7 days
- Side effects occur with EN or caloric goals cannot be achieved
- Patient has high stomal losses or short bowel syndrome requiring additional support 5
5. Assess for Refeeding Syndrome Risk
Monitor these parameters before and during PN initiation 2, 3:
- Baseline phosphate, potassium, and magnesium levels
- Blood glucose (risk of hypoglycemia in malnourished patients)
- Thiamine (vitamin B1) status—administer prior to glucose infusion in alcoholic liver disease or severe malnutrition 2
High-risk patients include 3:
- BMI <16 kg/m²
- Unintentional weight loss >15% in 3-6 months
- Little or no nutritional intake for >10 days
- Low baseline potassium, phosphate, or magnesium
6. Design PN Prescription
Macronutrient composition 9, 10:
- Glucose: 2-3 g/kg/day initially, up to 3-6 g/kg/day (50-60% of non-protein energy); maintain blood glucose <10 mmol/L 7, 2
- Lipids: Up to 1 g/kg/day for long-term PN (>6 months); 0.8-1.2 g/kg/day for short-term; use emulsions with lower n-6 content than pure soybean oil; maintain triglycerides <12 mmol/L 7, 9
- Amino acids: 1.2-1.5 g/kg/day for most patients; 0.8-1.2 g/kg/day in acute liver failure 2, 9
- Non-protein energy to nitrogen ratio: 100-150 kcal per gram of nitrogen 9
- Provide water-soluble vitamins and trace elements daily from day 1 of PN
- Adjust for increased losses in patients with high stomal output or continuous renal replacement therapy 12
7. Establish Venous Access
For anticipated PN duration 9:
- Short-term (<3 months): Peripherally inserted central catheter (PICC) or non-tunneled central line
- Long-term (>3 months): Tunneled central catheter via subclavian or internal jugular vein
- Home PN: Tunneled catheter preferred; implanted ports acceptable alternative
- Use single-lumen catheters to minimize infection risk 9
8. Implement Monitoring Protocol
Daily monitoring during PN initiation 2, 10:
- Blood glucose every 6 hours initially
- Electrolytes (especially phosphate, potassium, magnesium) daily for first 3-5 days
- Fluid balance and weight
- Signs of feeding intolerance or complications
Weekly monitoring once stable 5, 9:
- Complete metabolic panel including liver function tests
- Triglycerides (maintain <12 mmol/L)
- Albumin and prealbumin
- Micronutrient levels as indicated
9. Determine PN Administration Strategy
Cyclic PN is recommended 9:
- Infuse over 10-14 hours overnight when possible
- Allows patient mobility and oral intake during day
- Improves quality of life for long-term PN patients
- Use infusion pumps for controlled delivery 9
- Begin at 50% of calculated requirements in severely malnourished patients
- Advance to full requirements over 3-5 days
- Monitor for refeeding syndrome throughout advancement
10. Plan for Ongoing Reassessment
- Provide small amounts of enteral feeding (10-30 ml/h) even during PN to maintain gut integrity when possible
- Reassess EN feasibility every 3-5 days
- Transition back to EN as soon as gastrointestinal function permits
Functional outcome monitoring 3:
- Handgrip strength
- Activities of daily living
- Quality of life measures
- These may be more appropriate than weight alone in polymorbid patients
Critical Pitfalls to Avoid
- Do not delay PN in severely malnourished patients waiting for EN tolerance to improve beyond 7-10 days 4
- Avoid overfeeding in ICU patients—hypocaloric feeding may be safer initially; do not exceed actual energy expenditure 6, 10
- Never start glucose infusion without ensuring adequate thiamine in at-risk patients (alcoholism, severe malnutrition) 2
- Do not use PN when EN is feasible and tolerated—EN maintains gut integrity and has lower infection risk 6
- Avoid excessive lipid provision (>1 g/kg/day) in long-term PN due to risk of cholestasis and liver disease 5, 9